{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:12:21Z","timestamp":1773306741405,"version":"3.50.1"},"reference-count":29,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"PRO.MED.CS, Praha a.s., Prague, the Czech Republic"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therap Adv Gastroenterol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Functional dyspepsia (FD) is a prevalent condition characterized by symptoms such as postprandial fullness, early satiety, and epigastric pain, which significantly affect daily activities and quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>This study aimed to assess the effectiveness of itopride hydrochloride, a prokinetic agent, in reducing the severity of these symptoms among patients with FD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>In this noninterventional, observational, post-authorization, prospective, multicenter study (without placebo or comparator) 339 patients with FD were treated with itopride and followed over a period of 12\u2009weeks. The study clinical protocol ITO-NPS-01-PMCS-2021 was approved by the Ethical Committee of the University Hospital Brno and Faculty of Medicine, Masaryk University, Brno (ORG No: 100022981\/LOC No:100031711), and reported to the Czech State Institute of Drug Control (identifier: 2110140000) following local legislation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The patients\u2019 symptoms were quantified at baseline, 3\u20136\u2009weeks, and 7\u201312\u2009weeks using the modified \u201cLeuven Postprandial Distress Scale.\u201d Statistical analysis involved the Wilcoxon test, Mann\u2013Whitney test, and Kruskal\u2013Wallis test, focusing on changes in symptom scores and following potential adverse effects (AEs) over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Itopride hydrochloride treatment resulted in a statistically significant median reduction in symptom severity scores from baseline to the first and second follow-up assessments. The scores decreased by 5\u2009points at the first follow-up and by 8\u2009points at the second follow-up across all FD patient subgroups, regardless of age and gender. The study also observed minimal AEs, with only 2% of patients experiencing mild symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Itopride appears to be a safe and effective treatment for reducing symptom severity in patients with FD. The findings support the use of itopride in clinical settings, providing evidence of its benefit in managing this challenging condition. This study brings additional clinical knowledge from the eastern European population (Czechs) to data published by the ROME IV foundation with various cohorts of patients with FD and its results further demonstrate the long-term benefits and safety profile of itopride with minimal non-AEs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17562848261417732","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:15:01Z","timestamp":1771668901000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of itopride on functional dyspepsia symptom progression: a multicenter noninterventional postregistration study"],"prefix":"10.1177","volume":"19","author":[{"given":"Jiri","family":"Dolina","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, 625 00, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Tack","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5181-7756","authenticated-orcid":false,"given":"Serhiy","family":"Forostyak","sequence":"additional","affiliation":[{"name":"Department of Burns and Plastic Surgery, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolien","family":"Schol","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radek","family":"Kroupa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilja","family":"Tachec\u00ed","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine\u2014Gastroenterology, Charles University, Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bortl\u00edk","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"Pavl\u00edk","sequence":"additional","affiliation":[{"name":"Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Novotny","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and University Hospital Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.011"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.04.014"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.06.043"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.059"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-006-1818-x"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0258-6"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04493.x"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000072"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20233067"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05011.x"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i48.7371"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.013"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2011.06633.x"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16072"},{"key":"e_1_3_5_16_2","article-title":"Prokinetics for functional dyspepsia","volume":"10","author":"Pittayanon R","year":"2018","unstructured":"Pittayanon R, Yuan Y, Bollegala NP, et al. Prokinetics for functional dyspepsia. Cochrane Database Syst Rev 2018; 10: CD009431.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-017-0639-0"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14774"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1109510"},{"key":"e_1_3_5_20_2","article-title":"Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia","volume":"102","author":"Amarapurkar DN","year":"2004","unstructured":"Amarapurkar DN, Rane P. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia. J Indian Med Assoc 2004; 102: 735\u2013737, 760.","journal-title":"J Indian Med Assoc"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052639"},{"key":"e_1_3_5_22_2","first-page":"1878","article-title":"Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies","volume":"54","author":"Chiba T","year":"2007","unstructured":"Chiba T, Tokunaga Y, Ikeda K, et al. Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies. Hepatogastroenterology 2007; 54: 1878\u20131881.","journal-title":"Hepatogastroenterology"},{"key":"e_1_3_5_23_2","first-page":"626","article-title":"Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia","volume":"52","author":"Sawant P","year":"2004","unstructured":"Sawant P, Das HS, Desai N, et al. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia. J Assoc Physicians India 2004; 52: 626\u2013628.","journal-title":"J Assoc Physicians India"},{"key":"e_1_3_5_24_2","first-page":"387","article-title":"Efficacy and tolerability of itopride hydrochloride in patients with non-ulcer dyspepsia","volume":"101","author":"Shenoy KT","year":"2003","unstructured":"Shenoy KT, Veenasree, Leena KB. Efficacy and tolerability of itopride hydrochloride in patients with non-ulcer dyspepsia. J Indian Med Assoc 2003; 101: 387\u2013388.","journal-title":"J Indian Med Assoc"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.132449"},{"key":"e_1_3_5_26_2","first-page":"708","article-title":"Evaluation of new gastro-intestinal prokinetic (ENGIP-II) study","volume":"103","author":"Walwaikar PP","year":"2005","unstructured":"Walwaikar PP, Kulkarni SS, Bargaje RS. Evaluation of new gastro-intestinal prokinetic (ENGIP-II) study. J Indian Med Assoc 2005; 103: 708\u2013709.","journal-title":"J Indian Med Assoc"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S53027"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.09.002"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.18203\/2319-2003.ijbcp20174773"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/17562848251321123"}],"container-title":["Therapeutic Advances in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848261417732","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562848261417732","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848261417732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:49:18Z","timestamp":1773240558000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562848261417732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":29,"alternative-id":["10.1177\/17562848261417732"],"URL":"https:\/\/doi.org\/10.1177\/17562848261417732","relation":{},"ISSN":["1756-2848","1756-2848"],"issn-type":[{"value":"1756-2848","type":"print"},{"value":"1756-2848","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"article-number":"17562848261417732"}}